撤回：Nrf2：脆性X综合征中的一个新治疗靶点受NNZ2566调控。
Retracted: Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566.
作者信息
Deacon R M J, Hurley M J, Rebolledo C M, Snape M, Altimiras F J, Farías L, Pino M, Biekofsky R, Glass L, Cogram P
机构信息
Biomedicine Division, Centre for Systems Biotechnology, Fraunhofer Research Foundation, Santiago, Chile.
Gen.DDI Ltd, London, UK.
出版信息
Genes Brain Behav. 2017 Sep;16(7):739. doi: 10.1111/gbb.12373. Epub 2017 May 12.
Retraction: "Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566" by R. M. J. Deacon, M. J. Hurley, C. M. Rebolledo, M. Snape, F. J. Altimiras, L. Farías, M. Pino, R. Biekofsky, L. Glass and P. Cogram. The above article, from Genes, Brain and Behavior, published online on 12th May 2017 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor in Chief, Andrew Holmes and John Wiley & Sons Ltd. The retraction has been agreed as all authors cannot agree on a revised author order, and at least one author continues to dispute the original order. In this case, the original article is being retracted on the grounds that the journal does not have permission to publish. Reference: Deacon, R. M. J., Hurley, M. J., Rebolledo, C. M., Snape, M., Altimiras, F. J., Farías, L., Pino, M., Biekofsky, R., Glass, L. and Cogram, P. (2017), Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566. Genes, Brain and Behavior. doi:10.1111/gbb.12373.
撤稿声明
R. M. J. 迪肯、M. J. 赫尔利、C. M. 雷博莱多、M. 斯内普、F. J. 阿尔蒂米拉斯、L. 法里亚斯、M. 皮诺、R. B. 比科夫斯基、L. 格拉斯和P. 科格拉姆所著的《Nrf2：脆性X综合征中的一个新治疗靶点受NNZ2566调节》。上述文章发表于《基因、大脑与行为》，于2017年5月12日在Wiley Online Library（wileyonlinelibrary.com）在线发表，经期刊主编安德鲁·霍姆斯与约翰·威利父子有限公司协商后予以撤稿。撤稿是因为所有作者无法就修订后的作者顺序达成一致，且至少有一位作者继续对原顺序提出异议。在此情况下，原文章因期刊未获许可发表而被撤稿。参考文献：迪肯，R. M. J.，赫尔利，M. J.，雷博莱多，C. M.，斯内普，M.，阿尔蒂米拉斯，F. J.，法里亚斯，L.，皮诺，M.，比科夫斯基，R. B.，格拉斯，L. 和科格拉姆，P.（2017年），《Nrf2：脆性X综合征中的一个新治疗靶点受NNZ2566调节》。《基因、大脑与行为》。doi:10.1111/gbb.12373 。
Zotero 插件